U.S., Nov. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07224178) titled 'Left Atrial Strain and Cryptogenic Stroke' on Oct. 28.
Brief Summary: Cryptogenic stroke is a type of stroke in which the cause of the blood clot cannot be identified, leaving many patients without a clear treatment plan and at high risk for another stroke. Current medical guidelines recommend blood-thinning medication (anticoagulation) only when atrial fibrillation (AF) -an irregular heart rhythm- can be documented. However, AF may occur silently and remain undetected. Long term implantable (placed invasively under the skin) devices may be needed to capture these episodes.
AF is known to develop from disease of the left atrium, the...